Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01391 | 34762911 | J Biol Chem | Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. | 2021 | Details |
| A01392 | 34762779 | Arch Endocrinol Metab | Acoustic radiation force impulse elastography and liver fibrosis risk scores in severe obesity. | 2021 | Details |
| A01393 | 34762761 | FASEB J | Intracellular C3 prevents hepatic steatosis by promoting autophagy and very-low-density lipoprotein secretion. | 2021 | Details |
| A01395 | 34762106 | JAMA | Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01396 | 34761883 | Minerva Med | Inflammatory-nutritional scores in the diagnosis of NASH and liver fibrosis. | 2021 | Details |
| A01397 | 34761514 | J Cell Mol Med | Association between non-alcoholic fatty liver disease with the susceptibility and outcome of COVID-19: A retrospective study. | 2021 | Details |
| A01399 | 34760965 | Hepatobiliary Surg Nutr | Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity. | 2021 | Details |
| A01400 | 34759828 | Front Pharmacol | Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. | 2021 | Details |
| A01401 | 34759311 | Nat Commun | Elevated circulating follistatin associates with an increased risk of type 2 diabetes. | 2021 | Details |
| A01402 | 34759011 | Drug Metab Dispos | Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling. | 2021 | Details |
| A01403 | 34758930 | Arch Pediatr | The role of nutrition in non-alcoholic fatty liver disease treatment in obese children. | 2021 | Details |
| A01404 | 34758848 | Chin Med | Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagy. | 2021 | Details |
| A01405 | 34758532 | Zhonghua Yi Xue Za Zhi | [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database]. | 2021 | Details |
| A01406 | 34758326 | Cell Rep | m6A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity. | 2021 | Details |
| A01407 | 34757877 | Pediatr Ann | Approach to Pediatric Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01408 | 34757352 | Mol Omics | Identification of disease-associated microRNA in a diet-induced model of nonalcoholic steatohepatitis. | 2021 | Details |
| A01409 | 34757199 | Clin Gastroenterol Hepatol | Disease Progression Modeling for Economic Evaluation in Nonalcoholic Fatty Liver Disease-A Systematic Review. | 2021 | Details |
| A01410 | 34757198 | Clin Gastroenterol Hepatol | Longitudinal Changes in MR Elastography-based Biomarkers in Obese Patients Treated with Bariatric Surgery. | 2021 | Details |
| A01411 | 34757160 | Toxicology | The combined impact of decabromodiphenyl ether and high fat exposure on non-alcoholic fatty liver disease in vivo and in vitro. | 2021 | Details |
| A01413 | 34757046 | Mol Metab | Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis. | 2021 | Details |
| A01414 | 34756982 | Cell Mol Gastroenterol Hepatol | A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET. | 2021 | Details |
| A01415 | 34756030 | ACS Appl Mater Interfaces | Fluorescent Egg White-Based Carbon Dots as a High-Sensitivity Iron Chelator for the Therapy of Nonalcoholic Fatty Liver Disease by Iron Overload in Zebrafish. | 2021 | Details |
| A01416 | 34755918 | Environ Toxicol | Polystyrene nanoplastics potentiate the development of hepatic fibrosis in high fat diet fed mice. | 2021 | Details |
| A01417 | 34755544 | J Am Heart Assoc | Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries. | 2021 | Details |
| A01419 | 34755088 | iScience | Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. | 2021 | Details |
| A01420 | 34755002 | J Endocr Soc | Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care. | 2021 | Details |
| A01421 | 34754380 | World J Diabetes | Non-alcoholic fatty liver disease, diabetes medications and blood pressure. | 2021 | Details |
| A01422 | 34754150 | World J Gastroenterol | Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? | 2021 | Details |
| A01424 | 34753279 | Clin Mol Hepatol | MAFLD Enhances Clinical Practice for Liver Disease in the Asia-Pacific region. | 2021 | Details |
| A01425 | 34753223 | Liver Transpl | Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm. | 2021 | Details |
| A01426 | 34752964 | Clin Gastroenterol Hepatol | Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study. | 2021 | Details |
| A01428 | 34752711 | Annu Rev Pathol | Role of the Inflammasome in Liver Disease. | 2021 | Details |
| A01429 | 34750345 | Sci Rep | Albino mice with the point mutation at the tyrosinase locus show high cholesterol diet-induced NASH susceptibility. | 2021 | Details |
| A01430 | 34749893 | Nurs Clin North Am | Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01432 | 34749473 | Zhonghua Yu Fang Yi Xue Za Zhi | [Effects of (+)-catechin and epigallocatechin gallate on alcoholic fatty liver in mice models]. | 2021 | Details |
| A01433 | 34749354 | Hum Hered | Association of PNPLA3 I148M with Liver Disease Biomarkers in Latinos. | 2021 | Details |
| A01435 | 34746842 | Curr Res Physiol | High-fat diet-associated cognitive decline: Is zinc finger protein 1 (ZPR1) the molecular connection? | 2021 | Details |
| A01436 | 34746691 | iScience | Type 2 diabetes sex-specific effects associated with E167K coding variant in TM6SF2. | 2021 | Details |
| A01437 | 34746195 | Front Med (Lausanne) | Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies. | 2021 | Details |
| A01438 | 34746184 | Front Med (Lausanne) | Gene Signatures Detect Damaged Liver Sinusoidal Endothelial Cells in Chronic Liver Diseases. | 2021 | Details |
| A01439 | 34746177 | Front Med (Lausanne) | Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy. | 2021 | Details |
| A01440 | 34745924 | Avicenna J Phytomed | Gallic acid protects the liver against NAFLD induced by dust exposure and high-fat diet through inhibiting oxidative stress and repressing the inflammatory signaling pathways NF-kβ/TNF-α/IL-6 in Wistar rats. | 2022 | Details |
| A01441 | 34745420 | Oxid Med Cell Longev | The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD. | 2021 | Details |
| A01442 | 34745017 | Front Endocrinol (Lausanne) | The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH. | 2021 | Details |
| A01443 | 34743980 | Eur J Pharmacol | Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. | 2021 | Details |
| A01444 | 34743657 | Adipocyte | Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD. | 2021 | Details |
| A01445 | 34743485 | Ultrasonography | Hyperechoic pancreas on ultrasonography: an analysis of its severity and clinical implications. | 2021 | Details |
| A01446 | 34742934 | Arch Biochem Biophys | The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids. | 2021 | Details |
| A01447 | 34742814 | Gastroenterol Hepatol | Body composition and phase angle by bioimpedance in patients with MAFLD. | 2021 | Details |
| A01448 | 34741649 | Eur J Nutr | Magnesium intake is inversely associated with risk of non-alcoholic fatty liver disease among American adults. | 2021 | Details |
| A01449 | 34741554 | Hepatology | Global burden of NAFLD and chronic liver disease among adolescents and young adults. | 2021 | Details |
| A01455 | 34741169 | Nat Rev Immunol | Immune cell-mediated features of non-alcoholic steatohepatitis. | 2021 | Details |
| A01456 | 34740705 | J Hepatol | EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study. | 2021 | Details |
| A01457 | 34740672 | Toxicology | MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period. | 2021 | Details |
| A01459 | 34740573 | Metabolism | Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease. | 2021 | Details |
| A01460 | 34740314 | Mol Med | Nuclear receptors: a bridge linking the gut microbiome and the host. | 2021 | Details |
| A01461 | 34740106 | EBioMedicine | The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma. | 2021 | Details |
| A01462 | 34739937 | Nutrition | Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis. | 2021 | Details |
| A01463 | 34738990 | J Hypertens | Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus. | 2021 | Details |
| A01464 | 34738917 | Endocr Connect | Serum ferritin is correlated with non-alcoholic fatty liver disease in middle-aged and older patients with type 2 diabetes. | 2021 | Details |
| A01465 | 34737604 | J Inflamm Res | Curcumae Ameliorates Diethylnitrosamine-Induced Hepatocellular Carcinoma via Alteration of Oxidative Stress, Inflammation and Gut Microbiota. | 2021 | Details |
| A01466 | 34737121 | J Mol Cell Cardiol | NAFLD as a continuous driver in the whole spectrum of vascular disease. | 2021 | Details |
| A01467 | 34736960 | Cancer Lett | Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis. | 2021 | Details |
| A01468 | 34736591 | Pediatr Clin North Am | Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01469 | 34736535 | Cell Biosci | Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation. | 2021 | Details |
| A01470 | 34736334 | Ceska Gynekol | Conservative possibilities influencing PCOS syndrome - the importance of nutrition. | 2021 | Details |
| A01471 | 34736312 | Clin Mol Hepatol | U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases. | 2021 | Details |
| A01472 | 34734674 | Pediatr Obes | Exercise dose on hepatic fat and cardiovascular health in adolescents with excess of adiposity. | 2021 | Details |
| A01473 | 34734480 | J Cell Mol Med | Exercise ameliorates insulin resistance and improves ASK1-mediated insulin signalling in obese rats. | 2021 | Details |
| A01474 | 34734433 | J Gastroenterol Hepatol | New perspective on fecal microbiota transplantation in liver diseases. | 2022 | Details |
| A01475 | 34734369 | J Gastrointest Surg | The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. | 2021 | Details |
| A01476 | 34734090 | J Immunol Res | Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways. | 2021 | Details |
| A01477 | 34733981 | Ann Transl Med | TLR2 inhibition ameliorates the amplification effect of LPS on lipid accumulation and lipotoxicity in hepatic cells. | 2021 | Details |
| A01478 | 34733762 | J Lasers Med Sci | The Effect of Laser Therapy Along With Mediterranean Diet Versus Mediterranean Diet Only on Older Adults With Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2021 | Details |
| A01479 | 34732369 | Pharmacol Res | Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease. | 2021 | Details |
| A01480 | 34731006 | Sci Adv | Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD. | 2021 | Details |
| A01481 | 34730847 | J Ultrasound Med | A Pre-Release Algorithm With a Confidence Map for Estimating the Attenuation Coefficient for Liver Fat Quantification. | 2021 | Details |
| A01482 | 34730559 | Clin Transl Gastroenterol | Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents. | 2021 | Details |
| A01483 | 34729904 | Obes Rev | Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery. | 2021 | Details |
| A01484 | 34729306 | Acta Pharm Sin B | 3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing. | 2021 | Details |
| A01485 | 34728268 | Presse Med | Complications of lipodystrophy syndromes. | 2021 | Details |
| A01486 | 34728047 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Research Progress of Quantitative Ultrasound Assessment of Liver Steatosis in Non-alcoholic Fatty Liver Disease]. | 2021 | Details |
| A01487 | 34727818 | Expert Opin Ther Targets | A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH). | 2021 | Details |
| A01488 | 34727379 | Biomed Chromatogr | Lipidomic-based investigation into the therapeutic effects of polyene phosphatidylcholine and Babao Dan on rats with non-alcoholic fatty liver disease. | 2021 | Details |
| A01489 | 34726820 | Intern Med J | Clinical relevance of Shear Wave Elastography compared with Transient Elastography and other markers of liver fibrosis - a cross-sectional study. | 2022 | Details |
| A01490 | 34726357 | J Pediatr Endocrinol Metab | Increased hepcidin levels and non-alcoholic fatty liver disease in obese prepubertal children: a further piece to the complex puzzle of metabolic derangements. | 2021 | Details |
| A01491 | 34726318 | Diabetes Obes Metab | Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke. | 2021 | Details |
| A01492 | 34726148 | Proc Nutr Soc | Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism. | 2021 | Details |
| A01496 | 34724062 | J Clin Endocrinol Metab | The Effect of High-intensity Interval Training vs Moderate-intensity Continuous Training on Liver Fat: A Systematic Review and Meta-Analysis. | 2022 | Details |
| A01497 | 34723254 | JPGN Rep | Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints. | 2021 | Details |
| A01498 | 34722615 | Front Nutr | Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice. | 2021 | Details |
| A01499 | 34722411 | Can J Gastroenterol Hepatol | Anatomical Brain Changes and Cognitive Abilities in Patients with Obstructive Sleep Apnea Syndrome and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01500 | 34722175 | J Clin Transl Hepatol | Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01501 | 34722019 | Cureus | Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review. | 2021 | Details |
| A01502 | 34721326 | Front Microbiol | Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota. | 2021 | Details |
| A01503 | 34719928 | J Agric Food Chem | Erythritol Improves Nonalcoholic Fatty Liver Disease by Activating Nrf2 Antioxidant Capacity. | 2021 | Details |
| A01504 | 34719614 | J Nutr Sci Vitaminol (Tokyo) | Effect of Hyperbaric Oxygen Therapy (HBOT) on Insulin Resistance Associated with Abdominal Obesity in Wistar Rats with Dietary Sucrose-Induced Metabolic Syndrome. | 2021 | Details |
| A01505 | 34718898 | Egypt Heart J | The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography. | 2021 | Details |
| A01506 | 34718870 | J Gastroenterol | Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review. | 2021 | Details |
| A01507 | 34717726 | Trials | Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study). | 2021 | Details |